BioPower Operations Corp

As of May 31, 2023, BioPower Operations Corp carries a market capitalization of 12.38M, placing it among publicly traded companies globally. Its enterprise value stands at 15.01M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of May 31, 2023, BioPower Operations Corp has 45.87M shares outstanding.

These figures are as of May 31, 2023. The price-to-sales ratio is 98.49, and the price-to-book ratio stands at -1.80.

These figures are as of May 31, 2023. The EV/Sales ratio of 120.08 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 15.01M versus a market cap of 12.38M, with the gap driven by net debt and cash on the balance sheet.

As of May 31, 2023, BioPower Operations Corp maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -38.17, indicating conservative leverage, while an interest coverage ratio of -18.65 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended May 31, 2023. Return on assets (ROA) is negative at -1,969.20, reflecting losses generated across the asset base. The company generates approximately 17,857.14 in revenue per employee across its workforce of 7.00, a quick read on workforce productivity versus industry peers.

As of the close on September 30, 2026, BioPower Operations Corp's stock has gained approximately 9900.00% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.10.

Over the twelve months ended May 31, 2023, BioPower Operations Corp generated 125,000.00 in revenue and converted that into -6.17M in net income, yielding earnings per share of -0.14. EBITDA reached -5.85M, while operating income came in at -5.85M.

As of May 31, 2023, BioPower Operations Corp holds - - in cash and equivalents against 2.62M in total debt, resulting in a net debt position of 2.62M. Total book value stands at -6.88M, with working capital of -6.88M providing operational flexibility.

BioPower Operations Corp produced 128,739.00 in operating cash flow over the twelve months ended May 31, 2023.

These figures cover the twelve months ended May 31, 2023. The operating margin of -4,682.44 and net profit margin of -4,934.01 provide insight into operational efficiency.

These figures cover the twelve months ended May 31, 2023. Free cash flow yield stands at 1.05, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt.

BioPower Operations Corp's most recent stock split took place on September 10, 2013 with a 5:1 split ratio.

As of May 31, 2023, BioPower Operations Corp has an Altman Z-Score of -3,740.02, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.